Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (321-330 of 519) with videos related to

Pageof 52
Sort By:
Diagnostics (Basel, Switzerland)|April 30, 2021
Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate CancerWajahat Khatri, Hyun Woo Chung, Rudolf A Werner, et al.
Molecular Cancer Research : MCR|December 10, 2024
Cells in the Polyaneuploid Cancer Cell State Are PrometastaticMikaela M Mallin, Louis T A Rolle, Michael J Schmidt, et al.
The Journal of Urology|April 7, 2020
Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate CancerMark C Markowski, Ramy Sedhom, Wei Fu, et al.
Journal of Cellular Biochemistry|January 31, 2018
Integrin alpha V beta 3 targeted dendrimer-rapamycin conjugate reduces fibroblast-mediated prostate tumor progression and metastasisElliott E Hill, Jin Koo Kim, Younghun Jung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 10, 2016
Semiquantitative Parameters in PSMA-Targeted PET Imaging with <sup>18</sup>F-DCFPyL: Variability in Normal-Organ UptakeXin Li, Steven P Rowe, Jeffrey P Leal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2019
Prospective Evaluation of PSMA-Targeted <sup>18</sup>F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate CancerSteven P Rowe, Scott P Campbell, Margarita Mana-Ay, et al.
European Urology|April 12, 2021
A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate CancerMohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.
Clinical Genitourinary Cancer|November 26, 2015
PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?Steven P Rowe, Margarita Mana-Ay, Mehrbod S Javadi, et al.
Cancer Research|September 17, 2017
Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone MicroenvironmentRebeca San Martin, Ravi Pathak, Antrix Jain, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Cells in the Polyaneuploid Cancer Cell State are Pro-MetastaticMikaela M Mallin, Louis T A Rolle, Michael J Schmidt, et al.
Pageof 52

Showing results (321-330 of 519) with videos related to

Sort By:
Pageof 52
Diagnostics (Basel, Switzerland)|April 30, 2021
Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate CancerWajahat Khatri, Hyun Woo Chung, Rudolf A Werner, et al.
Molecular Cancer Research : MCR|December 10, 2024
Cells in the Polyaneuploid Cancer Cell State Are PrometastaticMikaela M Mallin, Louis T A Rolle, Michael J Schmidt, et al.
The Journal of Urology|April 7, 2020
Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate CancerMark C Markowski, Ramy Sedhom, Wei Fu, et al.
Journal of Cellular Biochemistry|January 31, 2018
Integrin alpha V beta 3 targeted dendrimer-rapamycin conjugate reduces fibroblast-mediated prostate tumor progression and metastasisElliott E Hill, Jin Koo Kim, Younghun Jung, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 10, 2016
Semiquantitative Parameters in PSMA-Targeted PET Imaging with <sup>18</sup>F-DCFPyL: Variability in Normal-Organ UptakeXin Li, Steven P Rowe, Jeffrey P Leal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2019
Prospective Evaluation of PSMA-Targeted <sup>18</sup>F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate CancerSteven P Rowe, Scott P Campbell, Margarita Mana-Ay, et al.
European Urology|April 12, 2021
A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate CancerMohammad S Sadaghiani, Sara Sheikhbahaei, Rudolf A Werner, et al.
Clinical Genitourinary Cancer|November 26, 2015
PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?Steven P Rowe, Margarita Mana-Ay, Mehrbod S Javadi, et al.
Cancer Research|September 17, 2017
Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone MicroenvironmentRebeca San Martin, Ravi Pathak, Antrix Jain, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Cells in the Polyaneuploid Cancer Cell State are Pro-MetastaticMikaela M Mallin, Louis T A Rolle, Michael J Schmidt, et al.
Pageof 52